These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3216492)

  • 1. [Improvement in anti-hemophilic preparations and its problems. 6. Function analysis of human plasma proteins passed through the microporous regenerated cellulose membrane (BMM) hollow fiber].
    Okuyama K; Fukushima Y; Miura Y; Honma R; Manabe S; Ishikawa G; Satani M; Komuro K
    Rinsho Ketsueki; 1988 May; 29(5):662-5. PubMed ID: 3216492
    [No Abstract]   [Full Text] [Related]  

  • 2. An attempt to prepare hepatitis B virus (HBV)-free plasma by ultrafiltration using microporous regenerated cellulose hollow fiber.
    Sekiguchi S; Ito K; Kobayashi M; Ikeda H; Manabe S; Tsurumi T; Ishikawa G; Satani M; Yamaguchi K
    Transfus Sci; 1990; 11(2):211-6. PubMed ID: 10149527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Removal of human immunodeficiency virus by filtration with microporous regenerated cellulose membrane and by fractionation with polyethylene glycol].
    Hamamoto Y; Yamamoto N
    Nihon Rinsho; 1989 Jan; 47(1):161-7. PubMed ID: 2724562
    [No Abstract]   [Full Text] [Related]  

  • 4. [Improvement in anti-hemophilic preparations and its problems. 2. Inadequacy of the heat treatment of factor concentrates on the inactivation of non-A, non-B hepatitis virus].
    Inagaki M; Osano M
    Rinsho Ketsueki; 1988 May; 29(5):635-9. PubMed ID: 3145994
    [No Abstract]   [Full Text] [Related]  

  • 5. [Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].
    Ikematsu S; Yorifuji H; Arai M; Fukutake K
    Rinsho Ketsueki; 1988 May; 29(5):628-34. PubMed ID: 3145993
    [No Abstract]   [Full Text] [Related]  

  • 6. [Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate purity and potency].
    Yoshioka A
    Rinsho Ketsueki; 1988 May; 29(5):649-54. PubMed ID: 3145996
    [No Abstract]   [Full Text] [Related]  

  • 7. Virus filtration of high-concentration monoclonal antibody solutions.
    Marques BF; Roush DJ; Göklen KE
    Biotechnol Prog; 2009; 25(2):483-91. PubMed ID: 19353736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method for removal of human immunodeficiency virus: filtration with porous polymeric membranes.
    Hamamoto Y; Harada S; Kobayashi S; Yamaguchi K; Iijima H; Manabe S; Tsurumi T; Aizawa H; Yamamoto N
    Vox Sang; 1989; 56(4):230-6. PubMed ID: 2763501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of virus safety of an antihemophilc factor IX by virus filtration process.
    Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS
    J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane filtration for virus removal.
    Brandwein H; Aranha-Creado H
    Dev Biol (Basel); 2000; 102():157-63. PubMed ID: 10794103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of virus through novel membrane filtration method.
    Manabe S
    Dev Biol Stand; 1996; 88():81-90. PubMed ID: 9119166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences.
    Heinrich D; Sugg U; Brackmann HH; Stephan W; Lissner R
    Dev Biol Stand; 1987; 67():311-7. PubMed ID: 3649316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric hollow fiber membranes for dialysis.
    Cross RA; Tyson WH; Cleveland DS
    Trans Am Soc Artif Intern Organs; 1971; 17():279-86. PubMed ID: 5158105
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of filtration characteristics in submerged microfiltration for drinking water treatment.
    Lee S; Park PK; Kim JH; Yeon KM; Lee CH
    Water Res; 2008 Jun; 42(12):3109-21. PubMed ID: 18387649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS and hepatitis prevention: the role of the rubber dam.
    Forrest WR; Perez RS
    Oper Dent; 1986; 11(4):159. PubMed ID: 3468490
    [No Abstract]   [Full Text] [Related]  

  • 16. Viral contamination of therapeutic proteins: a challenge for downstream processing.
    Harbour C; Woodhouse G; Barford JP; Spencer J; MacLeod AJ
    Aust J Biotechnol; 1991 Apr; 5(2):81-6. PubMed ID: 1369328
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental proof of contamination of blood components by (1-->3)-beta-D-glucan caused by filtration with cellulose filters in the manufacturing process.
    Nagasawa K; Yano T; Kitabayashi G; Morimoto H; Yamada Y; Ohata A; Usami M; Horiuchi T
    J Artif Organs; 2003; 6(1):49-54. PubMed ID: 14598125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research on the chemical inactivation of antibiotic activity in assays of sterility and contamination of pharmaceuticals.
    Negretti F; Casetta P
    J Chemother; 1991 Jan; 3 Suppl 1():76-9. PubMed ID: 12041793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light microscopic visualization of plasma intrusion into microporous hollow fibers.
    Cheng BT; Leonard EF
    ASAIO J; 1995; 41(4):863-72. PubMed ID: 8589468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental development of hollow cellulose membranes for blood detoxification].
    Holtz M; Bartsch D; Gensrich HJ; Gröbe V; Klinkmann H
    Z Urol Nephrol; 1983 Dec; 76(12):783-7. PubMed ID: 6670384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.